ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Promoter Vedanayagam Hospital Private Limited sold 1,50,000 equity shares of Shiva Texyarn Ltd via an off-market inter-se transfer valued at ₹2.39 Crore.
Vedanayagam Hospital Pvt Ltd, a promoter, inter-se transferred 1,50,000 Shiva Texyarn shares, cutting its stake from 66.04% to 64.88%. No separate consideration was disclosed for the transfer.
S K Sundararaman, a Shiva Texyarn promoter, acquired 1,50,000 shares via inter-se transfer. His stake rose from 0.39% to 1.55% of total voting capital.
Shiva Texyarn promoter Sundararaman acquired 1.5 lakh shares at Rs.159.53 from fellow promoter Vedanayagam Hospital Private Ltd. The inter-se transfer lifts his stake to 1.55%.
Promoter S K Sundararaman proposes to acquire 1,50,000 equity shares (1.16%) of Shiva Texyarn Ltd via an inter-se transfer. The transaction involves M/s. Vedanayagam Hospital Private Limited.
CARE Ratings has upgraded the credit ratings for Shiva Texyarn Ltd's bank facilities totaling ₹202.58 Crore. This reflects improved creditworthiness for the company.
Shiva Texyarn Limited conducted its 45th Annual General Meeting on August 27, 2026. Key resolutions included adopting audited financial statements and declaring a 6% equity dividend.
Shiva Texyarn Ltd reported revenue from operations of ₹73.8 Cr (-3.1% YoY) and net profit of ₹1.9 Cr (-24.0% YoY) for Q1 FY27.
Shiva Texyarn Ltd has set August 20, 2026, as the record date for dividend payment. The proposed dividend is ₹0.60 per equity share.
Shiva Texyarn Ltd announced its 45th Annual General Meeting for July 27, 2026. The company proposed a dividend of Rs.0.60 per equity share.
Shiva Texyarn Ltd has filed its 45th Annual Report for the financial year 2025-26. The filing includes financial statements and a notice for the upcoming AGM.
Shiva Texyarn Ltd scheduled a board meeting for August 6, 2026. The board will consider and approve un-audited financial results for the quarter ended June 30, 2026.